Skip to main content
Article
Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model
Biology of Blood and Marrow Transplantation (2013)
  • Johnnie J. Orozco, Fred Hutchinson Cancer Research Center
  • Aimee Kenoyer, Fred Hutchinson Cancer Research Center
  • Ethan Balkin, University of Washington
  • Donald K. Hamlin, University of Washington
  • Scott Wilbur, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Raya Mawad, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Mark D. Hylarides, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Paul V. O'Donnell, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Publication Date
January 2, 2013
DOI
10.1016/j.bbmt.2012.11.277
Citation Information
Johnnie J. Orozco, Aimee Kenoyer, Ethan Balkin, Donald K. Hamlin, et al.. "Anti-CD45 Pretargeted Radioimmunotherapy Prior to Bone Marrow Transplantation without Total Body Irradiation Facilitates Engraftment From Haploidentical Donors and Prolongs Survival in a Disseminated Murine Leukemia Model" Biology of Blood and Marrow Transplantation Vol. 19 Iss. 2 (2013)
Available at: http://works.bepress.com/john-pagel/135/